Next-generation proteomics technologies in Alzheimer’s disease: from clinical research to routine diagnostics
Authors:
Open Access
- 2 September 2023
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Proteomics
- Vol. 20 (7-9) , 143-150
Abstract
No abstract availableKeywords
Funding Information
- the Swedish Research Council
- the Swedish Research Council
This publication has 101 references indexed in Scilit:
- Label-free quantification in clinical proteomicsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- Increasing the Multiplexing Capacity of TMTs Using Reporter Ion Isotopologues with Isobaric MassesAnalytical Chemistry, 2012
- Label-Free Quantitative LC–MS Proteomics of Alzheimer’s Disease and Normally Aged Human BrainsJournal of Proteome Research, 2012
- Targeted mass spectrometry approaches for protein biomarker verificationJournal of Proteomics, 2011
- Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkersProteomics – Clinical Applications, 2008
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde”Clinical Anatomy, 1995
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992
- Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.Proceedings of the National Academy of Sciences of the United States of America, 1986